PIM1 and prostate cancer: These results are well in line with previous observations on the ability of Pim-1 and Pim-2 to enhance growth of PC-3 cell-derived subcutaneous prostate cancer xenografts [18], while here we demonstrate that Pim-3 is also equally effective.